Outcomes of living donor kidney transplantation from extended criteria donors to extended criteria recipients: A retrospective cohort study

Table 4 Donor and recipient outcomes for subgroup analysis post living donor kidney transplantation, n (%)

	Group 1	Group 2	Group 3	Group 4	P value
Delayed graft function	0	1	0	0	0.398
Perioperative bleeding	2	2	1	2	0.615
Surgical site infection	3	1	1	1	0.941
Incisional hernia	0	2	3	2	0.227
1-year recipient survival	100	100	97.5	100	0.433
1-year graft survival	100	100	97.5	100	0.433
1-year recipient eGFR	63.9 ± 15.3	55.9 ± 16.5	56.1 ± 14.6	58 ± 19.5	0.053
1-year donor eGFR	67 (15.2)	69 (14)	67.6 (15.7)	69.8 (14.2)	0.834
3-year recipient survival	98.1	97	97.4	89.5	0.451
3-year graft survival	98.1	97	90	90.9	0.383
3-year recipient eGFR	60 ± 19.3	52.3 ± 20.2	52 ± 16.7	51 ± 22.6	0.136
3-year donor eGFR	71.2 (15)	71.8 (15)	70 (14.7)	67.6 (15.1)	0.801
5-year recipient survival	97	92.8	85.3	82.4	0.170
5-year graft survival	97	96	86.7	82.3	0.143
5-year recipient eGFR	57.8 ± 21.6	51.7 ± 21.5	50.4 ± 22.3	45 ± 25.5	0.270
5-year rejection	9 (26.5)	3 (10.7)	6 (18.2)	1 (5.9)	0.247
5-year donor eGFR	70 (17.2)	71.7 (14.3)	72 (16)	72 (12)	0.568

Graft function follows normal distribution in all subgroups and is expressed as mean ± SD, whereas as for the donors it is expressed as median and interquartile range. eGFR: Estimated glomerular filtration rate.